LivaNova PLC
$4.22B- Market cap
- $4.45B
- Debt
- +$407.54M
- Cash
- −$635.55M
Capital structure 92% equity / 8% debt · EV / Revenue 3.04x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $4.45B · View financials
Snapshot Sep 8, 2026, 4:00 PM ET
FY 2026 · Mkt cap
Decision snapshot: LIVN stock price at premium vs TXT $80.70 current versus $23.29 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TXT's multiple
Implied fair value · at LIVN's multiple
Snapshot Sep 8, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: LIVN FY 2025 (ended Dec 31, 2025) · TXT FY 2026 (ended Jan 3, 2026). Fiscal years are not aligned.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Capital structure 92% equity / 8% debt · EV / Revenue 3.04x
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 58% equity / 42% debt
TXT carries the larger enterprise value at $23.72B against $4.22B; TXT trades on the lower EV / Revenue multiple (1.60x vs 3.04x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
LivaNova PLC · implied price per share
Bear
$33.79
Base
$38.91
Bull
$45.57
Textron Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.34x
1.28x
Net debt / EBITDA
Leverage against operating earnings
2.13x
—
Cash and equivalents
Liquid reserves on the balance sheet
$635.55M
—
Total debt
Interest-bearing obligations outstanding
$407.54M
$10.04B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Medtronic plc
LIVN vs MDT
ABBOTT LABORATORIES
LIVN vs ABT
BAXTER INTERNATIONAL INC
LIVN vs BAX
BOSTON SCIENTIFIC CORP
LIVN vs BSX
BOEING CO
LIVN vs BA
LOCKHEED MARTIN CORP
LIVN vs LMT
NORTHROP GRUMMAN CORP /DE/
LIVN vs NOC
Howmet Aerospace Inc.
LIVN vs HWM
CURTISS WRIGHT CORP
LIVN vs CW
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.